Evidence map›Paper›PMID 31905171›Full record

ArticleAging2020

ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.

Xin Chen, Lijie Huang, Yang Yang, Suhua Chen, Jianjun Sun, Changcheng Ma, Jingcheng Xie, Yongmei Song, Jun Yang

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Microtubule Minus-End Binding Proteins in Cancer: Advances.Diagnostics (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Annals of translational medicine · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Xin ChenDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Lijie HuangBeijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Yang YangDepartment of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Suhua ChenDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Jianjun SunDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Changcheng MaDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Jingcheng XieDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Yongmei SongState Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Jun YangDepartment of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.
Peking University · CNPeking University Third Hospital · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNFourth Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence has indicated that the disorganized expression of certain genes promotes tumour progression. In this study, we elucidate the potential key differentially expressed genes (DEGs) between glioblastoma (GBM) and normal brain tissue by analysing three different mRNA expression profiles downloaded from the Gene Expression Omnibus (GEO) database. DEGs were sorted, and key candidate genes and signalling pathway enrichments were analysed. In our analysis, the highest fold change DEG was found to be abnormal spindle-like microcephaly associated (ASPM). The ASPM expression pattern from the database showed that it is highly expressed in GBM tissue, and patients with high expression of ASPM have a poor prognosis. Moreover, ASPM showed aberrantly high expression in GBM cell lines. Loss-of-function assay indicated that ASPM enhances tumorigenesis in GBM cells

Indexed as

G1 Phase Cell Cycle CheckpointsWnt Signaling PathwayAnimalsCell Line, TumorCell ProliferationCell Transformation, NeoplasticComputational BiologyDatabases, GeneticDisease Models, AnimalDisease ProgressionGene Expression ProfilingGene Expression Regulation, NeoplasticGene OntologyGlioblastomaHumansNerve Tissue ProteinsASPM protein, humanNerve Tissue ProteinsASPMbioinformatical analysiscell cycleglioblastomaWnt-β-catenin signaling

Identifiers

PMID31905171
PMCPMC6977704
OpenAlexW3000460980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.